(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Assessment of Burden of Chronic Condition tool was ...

As evidenced by a debate at the CHEST Annual Meeting 2023, the pulmonology community disagrees on whether the overlap of asthma and chronic obstructive pulmonary disease (COPD) is a distinct entity ...

Connect Biopharma Holdings Limited announced promising results from its clinical studies of rademikibart, an investigational anti-IL-4Rα antibody, at the EAACI 2025 Annual Congress. The data show that ...

Researchers found that those with both type 2 diabetes and chronic obstructive pulmonary disease (COPD) had lower all-cause and respiratory-cause mortality survival probabilities than those without ...

Individuals were more likely to have diabetes when a full sibling had asthma vs when a sibling did not have asthma. The link between asthma and type 2 diabetes (T2D) is not only due to body mass index ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with moderate or severe COPD receiving 300 mg of ...

Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...

Dupixent inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and the program focuses on a specific population of people with evidence of type 2 inflammation.

Paris and Tarrytown, NY May 31, 2024. The US Food and Drug Administration (FDA) has extended by three months the target action date of its priority review of the supplemental Biologics License ...